Novo Nordisk (NVO) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial.
Read more...
Hence then, the article about novo nordisk stock surges 12 as an ozempic alternative shows promising weight loss was published today ( ) and is available on Quartz ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Novo Nordisk stock surges 12% as an Ozempic alternative shows promising weight loss )
Last updated :
Also on site :
- Namibia: Parliament Fears 'Power Vacuum' in Petroleum Bill
- Global Time and Attendance Software Market to Reach USD 6.32 Billion by 2032, Growing at a CAGR of 7.35%, Reports MarkNtel Advisors
- Nearly half a million Lloyds customers hit by data breach after IT glitch
